Here’s How Eli Lilly and Company (LLY) Contributed to Parnassus Core Equity Fund’s Performance
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
Eli Lilly (NYSE:LLY) Advances Alopecia Study Results Amid 4% Share Price Rise
Eli Lilly (NYSE:LLY) has recently unveiled significant advancements across its product line, including promising results from ...
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Here’s Why Eli Lilly and Company (LLY) has Come Under Pressure
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...
Eli Lilly and Company (LLY) Management presents at Leerink 2025 Global Healthcare Conference (Transcript)
Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ETCompany ParticipantsLucas Montarce - CFOMike Czapar ...
Wegovy Gets Cheaper! Novo Nordisk Takes on Eli Lilly as Obesity Drug Battle Heats Up
Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...
Fidelity Select Health Care Portfolio Q4 2024 Review
Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...
Here’s What Weighed on CME Group’s (CME) Valuation
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
Zacks Investment Research on MSN5d
Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More
Bayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm ...
Investing Snacks15h
Eli Lilly’s Bold Moves Fuel Stock Surge and Expansion
Eli Lilly revealed major advancements in its alopecia and atopic dermatitis studies, likely driving its 3.77% stock rise. The ...
7 Best Weight Loss Drug Stocks to Buy in 2025
The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...